179 related articles for article (PubMed ID: 27690341)
1. Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex.
Berardi R; Morgese F; Santinelli A; Onofri A; Biscotti T; Brunelli A; Caramanti M; Savini A; De Lisa M; Ballatore Z; Pompili C; Salati M; Mazzanti P; Torniai M; Cascinu S
Oncotarget; 2016 Dec; 7(50):82648-82657. PubMed ID: 27690341
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
[TBL] [Abstract][Full Text] [Related]
4. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
Anagnostou VK; Lowery FJ; Zolota V; Tzelepi V; Gopinath A; Liceaga C; Panagopoulos N; Frangia K; Tanoue L; Boffa D; Gettinger S; Detterbeck F; Homer RJ; Dougenis D; Rimm DL; Syrigos KN
BMC Cancer; 2010 May; 10():186. PubMed ID: 20459695
[TBL] [Abstract][Full Text] [Related]
5. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas.
Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK
Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
[TBL] [Abstract][Full Text] [Related]
7. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I
Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer.
Kim NY; Pyo JS
Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757
[TBL] [Abstract][Full Text] [Related]
9. Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
Refaat B; Aslam A; Idris S; Almalki AH; Alkhaldi MY; Asiri HA; Almaimani RA; Mujalli A; Minshawi F; Alamri SA; AlHussain MI; Baltow BA; Alqasmi MH; Basfar GT; Alosaimi OM; Muhayya IA
Front Endocrinol (Lausanne); 2023; 14():1187259. PubMed ID: 37206439
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
12. Orai3 is a predictive marker of metastasis and survival in resectable lung adenocarcinoma.
Benzerdjeb N; Sevestre H; Ahidouch A; Ouadid-Ahidouch H
Oncotarget; 2016 Dec; 7(49):81588-81597. PubMed ID: 27835593
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
14. SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer.
Azuma Y; Yokobori T; Mogi A; Altan B; Yajima T; Kosaka T; Onozato R; Yamaki E; Asao T; Nishiyama M; Kuwano H
J Surg Oncol; 2015 Aug; 112(2):231-7. PubMed ID: 26180037
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
16. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
[TBL] [Abstract][Full Text] [Related]
17. Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer.
Grant L; Banerji S; Murphy L; Dawe DE; Harlos C; Myal Y; Nugent Z; Blanchard A; Penner CR; Qing G; Pitz MW
Horm Cancer; 2018 Aug; 9(4):288-294. PubMed ID: 29915882
[TBL] [Abstract][Full Text] [Related]
18. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
Ritter JH; Dresler CM; Wick MR
Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
[TBL] [Abstract][Full Text] [Related]
19. Gender Differences in Long-Term Survival after Surgery for Non-Small Cell Lung Cancer.
Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Nomura Y
Thorac Cardiovasc Surg; 2016 Sep; 64(6):507-14. PubMed ID: 26366891
[TBL] [Abstract][Full Text] [Related]
20. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]